Heart Disease Trial, Recruiting NCT06711666 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06711666
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the mother:

  • Women who are at least 18 years old
  • Women who are currently pregnant
  • Women whose unborn baby has been diagnosed with a serious type of congenital heart disease (a heart condition present before birth that can affect how well the baby's blood carries oxygen after delivery)
  • Women who are between 28 and 38 weeks pregnant at the time of joining the study
  • Women who are receiving medical care at one of the three participating hospitals (Montpellier, Necker Children's Hospital in Paris, or Bordeaux)
  • Women for whom at least 4 weeks have passed since their baby's heart condition was first diagnosed
  • Women who are affiliated with the French social security system

For the father or co-parent:

  • The co-parent of a pregnant woman already participating in the study
  • At least 18 years old
  • Affiliated with the French social security system

For the child:

  • A child born to a mother already in the study, whose heart condition was diagnosed before birth and is not linked to any other known condition
  • Both parents must have given written consent
  • The child must be affiliated with the French social security system

Who may not be able to join:

For the mother:

  • Women who do not wish to participate
  • Women who are considering ending the pregnancy
  • Women whose baby's heart condition is associated with another condition known to affect brain development, such as certain genetic syndromes (for example, trisomies or multiple abnormalities)
  • Women who are not able to understand the study instructions or complete the required questionnaires
  • Women who currently have a significant psychiatric condition, such as untreated major depression, severe anxiety, or psychotic disorders — women in this situation would be referred to a specialist for support
  • Women who are under legal guardianship

For the father or co-parent:

  • Those who do not wish to participate
  • Those who have a severe psychiatric condition, such as severe depression or psychotic disorders, whether or not they are receiving treatment
  • Those who are under legal guardianship

After joining — reasons a participant may be removed from the study:

For the mother:

  • If the child does not have heart surgery within 60 days of birth

For the child:

  • If a genetic condition or brain abnormality is identified that would make assessing the child's development difficult

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 330603830737

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Registry
ClinicalTrials.gov
Start date
27 June 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Global Mental Health Self-questionnaire, The Symptom Checklist-90-Revised SCL-90 R (min score 20 - max score 80); Bayley Scales of Infant and Toddler Development (BAYLEY-4) (min score 50- max score 150)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov